Chr Hansen steps up pharma production
Danish ingredients company Chr Hansen has ramped up its production capacity in the US for its pharmaceutical products via a $10 million (€8.2m) expansion of its facilities in Stoughton in the US.
Danish ingredients company Chr Hansen has ramped up its production capacity in the US for its pharmaceutical products via a $10 million (€8.2m) expansion of its facilities in Stoughton in the US.
Innercap Technologies has developed a new capsule drug delivery system that makes it possible to combine two incompatible drug compounds into a single dosage unit.
Agilent Technologies has launched a microfluidics-based technology for liquid chromatography/mass spectrometry (LC/MS)- widely used by scientists in protein research and pharmaceutical applications to separate and identify biological compounds - that...
Lanxess, the fine chemicals unit that is due to be spun out of Germany's Bayer next year, will be headed by Axel Westerhaus, currently in charge of the group's polyethers business in the US.
Novartis subsidiary Lek has opened a new plant in Romania that will supply antibiotic generics and ingredients to markets across Europe.